More than 40% of adults in the United States suffer from obesity. Obesity is inextricably
linked to many chronic illnesses like type‐2 diabetes mellitus, hypertension, hyperlipidemia …

Obesity is a chronic, recurring, progressive disease and a major public health problem
associated with several other diseases that lead to disability, morbidity, and mortality. The …

Introduction: Obesity is a rapidly increasing global health problem. The rates of obesity have
tripled over the past three decades and are predicted to rise even further. The need for safe …

Obesity is a chronic medical condition that is expected to become an indirect but leading
cause of mortality and morbidity. Obesity results in type 2 diabetes mellitus, insulin …

Obesity is an epidemic and a public health threat. Medical weight management remains one
of the options for the treatment of excess weight and recent advances have revolutionized …

Obesity is a growing epidemic and a major contributor to the global burden of disease.
Obesity strains the healthcare systems and has profound economic and psychosocial …

Pharmacologic agents to promote weight loss have been available for decades, and many
factors have contributed to the continued interest in identifying effective drugs to treat …

Importance Obesity affects approximately 19% of women and 14% of men worldwide and is
associated with increased morbidity. Antiobesity medications (AOMs) modify biological …

Introduction Pharmacotherapy is a useful adjunct when patients with obesity are unable to
achieve adequate benefit from lifestyle interventions. Areas covered This review covers the …

Current management of obesity includes three main arms: behavioral modification,
pharmacologic therapy, and bariatric surgery. Decades prior, the only pharmacological …